Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (1321-1330 of 1,467) with videos related to

Pageof 147
Sort By:
American Heart Journal|March 8, 2017
Population differences in associations of serotonin transporter promoter polymorphism (5HTTLPR) di- and triallelic genotypes with blood pressure and hypertension prevalenceRedford B Williams, George D Bishop, Brett C Haberstick, et al.
Annals of the Rheumatic Diseases|February 6, 2008
EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISITW Zhang, M Doherty, B F Leeb, et al.
Joint Bone Spine|December 19, 2015
Patient global assessment in psoriatic arthritis - what does it mean? An analysis of 223 patients from the Psoriatic arthritis impact of disease (PsAID) studySandra Tälli, Adrien Etcheto, Bruno Fautrel, et al.
Annals of the Rheumatic Diseases|May 16, 2014
Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatologyMaya H Buch, Lucia Silva-Fernandez, Loreto Carmona, et al.
Annals of the Rheumatic Diseases|January 26, 2023
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022Kevin L Winthrop, John D Isaacs, Philip J Mease, et al.
Annals of the Rheumatic Diseases|May 17, 2007
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including TherapeuticsG Bertsias, J P A Ioannidis, J Boletis, et al.
Arthritis Research & Therapy|August 11, 2018
Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate: the DINORA trialTanja Alexandra Stamm, Klaus Peter Machold, Daniel Aletaha, et al.
The Journal of Rheumatology|December 17, 2003
A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratoriesMarvin J Fritzler, Allan Wiik, Eng M Tan, et al.
Arthritis and Rheumatism|March 24, 1999
A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificityE M Tan, J S Smolen, J S McDougal, et al.
Joint Bone Spine|December 18, 2022
Patient-defined flares and disease activity worsening in 222 patients with psoriatic arthritis from 14 countriesMarlene Sousa, Ennio Lubrano, Josef S Smolen, et al.
Pageof 147

Showing results (1321-1330 of 1,467) with videos related to

Sort By:
Pageof 147
American Heart Journal|March 8, 2017
Population differences in associations of serotonin transporter promoter polymorphism (5HTTLPR) di- and triallelic genotypes with blood pressure and hypertension prevalenceRedford B Williams, George D Bishop, Brett C Haberstick, et al.
Annals of the Rheumatic Diseases|February 6, 2008
EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISITW Zhang, M Doherty, B F Leeb, et al.
Joint Bone Spine|December 19, 2015
Patient global assessment in psoriatic arthritis - what does it mean? An analysis of 223 patients from the Psoriatic arthritis impact of disease (PsAID) studySandra Tälli, Adrien Etcheto, Bruno Fautrel, et al.
Annals of the Rheumatic Diseases|May 16, 2014
Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatologyMaya H Buch, Lucia Silva-Fernandez, Loreto Carmona, et al.
Annals of the Rheumatic Diseases|January 26, 2023
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022Kevin L Winthrop, John D Isaacs, Philip J Mease, et al.
Annals of the Rheumatic Diseases|May 17, 2007
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including TherapeuticsG Bertsias, J P A Ioannidis, J Boletis, et al.
Arthritis Research & Therapy|August 11, 2018
Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate: the DINORA trialTanja Alexandra Stamm, Klaus Peter Machold, Daniel Aletaha, et al.
The Journal of Rheumatology|December 17, 2003
A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratoriesMarvin J Fritzler, Allan Wiik, Eng M Tan, et al.
Arthritis and Rheumatism|March 24, 1999
A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificityE M Tan, J S Smolen, J S McDougal, et al.
Joint Bone Spine|December 18, 2022
Patient-defined flares and disease activity worsening in 222 patients with psoriatic arthritis from 14 countriesMarlene Sousa, Ennio Lubrano, Josef S Smolen, et al.
Pageof 147